Leading Pharmaceutical Innovation: How to Win the Life Science Race

Oliver Gassmann*, Alexander Schuhmacher, Max von Zedtwitz, Gerrit Reepmeyer

*Corresponding author for this work

Research output: Book/ReportBookResearchpeer-review


This book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management methods in the drug development pipeline; new technologies as enablers for cutting-edge R&D; and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. New models and methods are illustrated with cases from Europe, the US, and Asia. This third fully revised edition was expanded to reflect the latest updates in open and collaborative innovation, the greater strategic importance of venture capital and early-stage investments, and the new range of emerging technologies now being put to use in pharmaceutical innovation.

Original languageEnglish
Place of PublicationCham
Number of pages179
ISBN (Print)9783319668321, 9783030097820
ISBN (Electronic)9783319668338
Publication statusPublished - 2018
Externally publishedYes

Cite this